Genmab — Juni 2020
-
"My experience with this drug [daratumumab] is very positive and it has become our standard of care for newly diagnosed patients," commented Mathew Maurer, MD, from Columbia University - in Amyloidosis already https://www.medpagetoday.com/meetingcoverage/eha/87084
-
E L.

-
Burde blive et tema, der er kæmpemæssige strukturelle problemer over there! Ville være lækkert med lidt røre i andedammen så biotek kan falde markant tilbage så der kan samles billigt op fordi uvidende investorer ikke fatter en bjælde og sælger i panik, lidt ligesom ved sidste valg.
-
Kan du sætte lidt flere ord på din observation. Følger med i auktion
nu -
Tillykke Stroka 12,43..Du ramte lukke kursen lige på kornet. Samme luk som US i går.
-
Tal lige om robotter der kan deres kram.

-
Modtaget tak
-
NBI +1,76%
-
God morgen.

-
God morgen

-
@Genmab
We are proud to share that Genmab’s Esther Breij, Ph.D., Senior Director Translational Research will present a poster entitled “Multifaceted mechanism of action of DuoHexaBody
-CD37 in pre-clinical B-cell lymphoma models” during June 22-24 at #AACR2020
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind